Phase 2/3Status unknown

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension and Hyperhomocysteinemia :a Double-blind Randomized Controlled Trial

Sponsor
Shenzhen Ausa Pharmed Co.,Ltd (Industry)
Enrolment
756 planned
Conditions
Essential Hypertension
Interventions
Amlodipine; amlodipine-FA tablet, low dose group; amlodipine-FA tablet ,high dose group
Ages
adults, older adults
Registry
NCT01848873

Full record on ClinicalTrials.gov

From the registry

To evaluate the efficacy of Amlodipine-folic Acid Tablets on reduction of blood pressure and plasma homocystein.

Primary outcomes

  • Combined effective rate of blood pressure and plasma homocysteine reduction

History

  1. Primary completion

  2. Registered

  3. Started

Papers citing this trial